Antibiotic exposure in infancy may boost Type 1 diabetes risk - but microbiota can help
Exposure to antibiotics during a key developmental window in infancy can stunt the growth of insulin-producing cells and may boost risk of diabetes later in life. But the research pinpoints specific microbes that may help those critical cells proliferate in early life.
Registered users, subscribers or members - SIGN IN
To continue reading this article
Membership
Included as a benefit
Members of Applied Microbiology International have unlimited access to The Microbiologist as a benefit of membership. Just sign in with your usual membership credentials.
Find out more about how to join.
Register
FREE
Want to read more before deciding on a subscription? It only takes a minute to sign up for a free account and you’ll get to enjoy more free content each month.
Subscribe
3.75 per month / £35 annually
Get unlimited access to The Microbiologist.